CN103263577B - Medicine composition for treating psoriasis - Google Patents

Medicine composition for treating psoriasis Download PDF

Info

Publication number
CN103263577B
CN103263577B CN201310218793.XA CN201310218793A CN103263577B CN 103263577 B CN103263577 B CN 103263577B CN 201310218793 A CN201310218793 A CN 201310218793A CN 103263577 B CN103263577 B CN 103263577B
Authority
CN
China
Prior art keywords
radix
weight portion
medicine composition
treatment
folium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310218793.XA
Other languages
Chinese (zh)
Other versions
CN103263577A (en
Inventor
雷加朋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310218793.XA priority Critical patent/CN103263577B/en
Publication of CN103263577A publication Critical patent/CN103263577A/en
Application granted granted Critical
Publication of CN103263577B publication Critical patent/CN103263577B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a medicine composition for treating psoriasis. The composition comprises the raw medicinal materials including radix angelicae, cortex dictamni, root of rehmannia, isatis root, moutan bark, schizonepeta, motherwort fruit, radix paeoniae alba, radix ophiopogonis, donkey-hide gelatin, poria cocos, lithospermum and the like. The medicine composition is prepared into clinically acceptable pills, capsules, tablets, granules, powder, decoction or oral liquid by adding conventional auxiliary materials according to conventional processes. The medicine composition disclosed by the invention has the effects of clearing heat, promoting diuresis, dispelling wind and arresting itching, has remarkable effects on treating psoriasis, and is free of toxic and side effect.

Description

One is treated psoriatic pharmaceutical composition
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to one and treat psoriatic pharmaceutical composition.
Background technology
Psoriasis is a kind of common chronic recurrent inflammatory skin disease, characteristic infringement is for being covered with multilamellar silvery white squama on red pimple or speckle, be apt to occur in extremity and stretch side, scalp and back, serious skin lesion can general whole body, and can occur that high heat, pustule, erythroderma sample change and the big or small arthropathy of whole body.The primary disease course of disease is long, and the sustainable several years, to many decades, can show effect during this time repeatedly.There is not medication and spontaneous recovery person also has the medication person of increasing the weight of, also have the patient who occurs the infringement of whole body erythroderma sample because of medication.Psoriatic can have renal damage, also can be with liver, and eye, gastrointestinal tract, the organ diseases such as cardiovascular.Pathogenesis is not yet illustrated, and thinks that at present psoriasis is an immune-mediated genetic dermatosis.
Summary of the invention
The object of the invention is to provide one to treat psoriatic pharmaceutical composition.
The present invention is achieved through the following technical solutions:
The crude drug of pharmaceutical composition of the present invention consists of:
Radix Angelicae Dahuricae 10-30 weight portion Cortex Dictamni 10-30 weight portion Radix Rehmanniae 6-18 weight portion
Radix Isatidis 10-30 weight portion Cortex Moutan 10-30 weight portion Herba Schizonepetae 5-15 weight portion
Fructus Leonuri 7-23 weight portion Radix Paeoniae Alba 12-38 weight portion 10-30 Radix Ophiopogonis weight portion
Colla Corii Asini 10-30 weight portion Poria 7-23 weight portion Radix Arnebiae (Radix Lithospermi) 10-30 weight portion
Radix Adenophorae (Radix Glehniae) 7-23 weight portion Herba Peristrophes 4-12 weight portion
Rhizoma Anemones Altaicae 4-12 weight portion Folium Indigoferae teysmannii 4-12 weight portion
Herba Veronicae Ciliatae 4-12 weight portion Folium Hibisci Rosae-Sinensis 6-18 weight portion Fructus Kochiae 6-18 weight portion
White Radix Solani Melongenae 7-23 weight portion Radix Angelicae Sinensis 7-23 weight portion Radix Salviae Miltiorrhizae 7-23 weight portion
Folium Lycii 10-30 weight portion Radix Tripterygii Wilfordii 10-30 weight portion.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
The Radix Angelicae Dahuricae 20 weight portion Cortex Dictamni 20 weight portion Radix Rehmanniae 12 weight portions
Radix Isatidis 20 weight portion Cortex Moutan 20 weight portion Herba Schizonepetae 10 weight portions
Fructus Leonuri 15 weight portion Radix Paeoniae Alba 25 weight portion weight portions Radix Ophiopogonis 20
Colla Corii Asini 20 weight portion Poria 15 weight portion Radix Arnebiae (Radix Lithospermi) 20 weight portions
Radix Adenophorae (Radix Glehniae) 15 weight portion Herba Peristrophes 8 weight portions
Rhizoma Anemones Altaicae 8 weight portion Folium Indigoferae teysmannii 8 weight portions
The Herba Veronicae Ciliatae 8 weight portion Folium Hibisci Rosae-Sinensis 12 weight portion Fructus Kochiae 12 weight portions
White Radix Solani Melongenae 15 weight portion Radix Angelicae Sinensis 15 weight portion Radix Salviae Miltiorrhizae 15 weight portions
Folium Lycii 20 weight portion Radix Tripterygii Wilfordii 20 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
The Radix Angelicae Dahuricae 12 weight portion Cortex Dictamni 28 weight portion Radix Rehmanniae 8 weight portions
Radix Isatidis 28 weight portion Cortex Moutan 12 weight portion Herba Schizonepetae 13 weight portions
Fructus Leonuri 9 weight portion Radix Paeoniae Alba 36 weight portion weight portions Radix Ophiopogonis 12
Colla Corii Asini 28 weight portion Poria 9 weight portion Radix Arnebiae (Radix Lithospermi) 28 weight portions
Radix Adenophorae (Radix Glehniae) 9 weight portion Herba Peristrophes 10 weight portions
Rhizoma Anemones Altaicae 6 weight portion Folium Indigoferae teysmannii 10 weight portions
The Herba Veronicae Ciliatae 6 weight portion Folium Hibisci Rosae-Sinensis 16 weight portion Fructus Kochiae 8 weight portions
White Radix Solani Melongenae 21 weight portion Radix Angelicae Sinensis 9 weight portion Radix Salviae Miltiorrhizae 21 weight portions
Folium Lycii 12 weight portion Radix Tripterygii Wilfordii 28 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
The Radix Angelicae Dahuricae 28 weight portion Cortex Dictamni 12 weight portion Radix Rehmanniae 16 weight portions
Radix Isatidis 12 weight portion Cortex Moutan 28 weight portion Herba Schizonepetae 7 weight portions
Fructus Leonuri 21 weight portion Radix Paeoniae Alba 14 weight portion weight portions Radix Ophiopogonis 28
Colla Corii Asini 12 weight portion Poria 21 weight portion Radix Arnebiae (Radix Lithospermi) 12 weight portions
Radix Adenophorae (Radix Glehniae) 21 weight portion Herba Peristrophes 6 weight portions
Rhizoma Anemones Altaicae 10 weight portion Folium Indigoferae teysmannii 6 weight portions
The Herba Veronicae Ciliatae 10 weight portion Folium Hibisci Rosae-Sinensis 8 weight portion Fructus Kochiae 16 weight portions
White Radix Solani Melongenae 9 weight portion Radix Angelicae Sinensis 21 weight portion Radix Salviae Miltiorrhizae 9 weight portions
Folium Lycii 28 weight portion Radix Tripterygii Wilfordii 12 weight portions.
Pharmaceutical composition of the present invention adds conventional adjuvant to make the pill of clinical acceptance, capsule, tablet, granule, powder, decoction or oral liquid according to common process.
Pharmaceutical composition of the present invention has clearing away heat-damp and promoting diuresis, effect of dispelling wind for relieving itching.Remarkable to treatment psoriasis effect, have no side effect.
Experimental example is used for further illustrating the present invention below, but is not limited to the present invention.
One, experimental example
1, clinical observation
Treatment group anthology invention capsule (according to embodiment 1 method preparation) treatment psoriasis 100 examples, wherein male's 50 examples, women's 50 examples.
Matched group selects painting capsule, is produced treatment psoriasis 100 examples, wherein male's 50 examples, women's 50 examples by Shanxi Kanghui Pharmaceutical Co., Ltd..
2, medicament selection
Treatment group: capsule of the present invention (according to embodiment 1 method preparation), treat three courses for the treatment of (9 days courses for the treatment of), oral, each serving 4, every day 3 times.
Matched group: painting capsule, produced by Shanxi Kanghui Pharmaceutical Co., Ltd., treat three courses for the treatment of (9 days courses for the treatment of), oral, each serving 4, every day 3 times, one after each meal.
3, diagnostic criteria
1. be the flat pimple of inflammatory that syringe needle is large when psoriasis onset.Be increased to gradually coin pale red and infiltrate speckle, boundary is clear, above covers multilamellar silvery white squama.Strike off gently surperficial squama, thunderclap goes out the shinny semitransparent thin film of one deck pale red, claims thin film phenomenon.Strike off again thin film, occur little petechia, claim petechial hemorrhage phenomenon.
2. skin lesion can occur in any site symmetry of health.Be apt to occur in elbow, knee joint is stretched side and head.A few patients refers to that (toe) first and mucosa also can be invaded.
3. the easy acute attack of psoriasis, chronic process, tendency recurrence.Morbidity is normal relevant with season.
4, criterion of therapeutical effect
" in cure the desease Standardization of diagnosis and curative effect " of implementing with reference to State Administration of Traditional Chinese Medicine 1994 drafted as follows:
Recovery from illness: tcm clinical practice symptom, sign disappear or substantially disappear;
Effective: tcm clinical practice symptom, sign obviously change;
Effective: tcm clinical practice symptom, sign all take a favorable turn;
Invalid: tcm clinical practice symptom, sign are all not improved;
5, therapeutic outcome
Table 1 is treated psoriatic Comparison of therapeutic
Group Treatment number Cure Effective Effectively Invalid Total effective rate
Treatment group 100 56 22 20 2 98%
Matched group 100 30 20 33 17 83%
6, conclusion
Treatment group and matched group are treated respectively three courses for the treatment of (9 days each courses for the treatment of), treatment group is taken the firm capsule of the present invention (according to embodiment 1 method preparation), matched group is taken painting capsule, produced by Shanxi Kanghui Pharmaceutical Co., Ltd., therapeutic outcome shows, treatment group total effective rate 98% of the present invention, matched group total effective rate 83%.Treatment group of the present invention is obviously better than matched group.
7, discuss
The Radix Angelicae Dahuricae in pharmaceutical composition of the present invention: warm in nature, acrid in the mouth.Enter lung, spleen, stomach warp.Function cures mainly: skin pruritus." the southern regions of the Yunnan Province book on Chinese herbal medicine ": the wind of the skin migration of dispelling, the only cold pain of the cold stomachache of stomach, whole body cold-damp pain.Cortex Dictamni: nature and flavor: hardship; Salty; Cold.Gui Jing: spleen channel; Lung meridian; Small intestine meridian; Stomach warp; Urinary bladder channel.There is heat clearing and damp drying, effect of the removing toxic substances of dispeling the wind." property of medicine opinion ": " control all pyretic toxicity wind, aversion to wind, wind skin ulcer, scabies are red rotten, and eyebrow loss of hairs is crisp, and musculus cutaneus is anxious, high fever aversion to cold.The Radix Rehmanniae: sweet, cold.GUIXIN, liver, kidney channel.Clearing away heat and cooling blood, yin nourishing, promotes the production of body fluid.Radix Isatidis: hardship, cold, nontoxic.Enter liver, stomach blood system.Heat clearing away, removing toxic substances, removing heat from blood, sore-throat relieving.Cortex Moutan: cold in nature, bitter in the mouth; Cool; Be slightly cold.GUIXIN; Liver; Kidney; Lung meridian.Clearing away heat and cooling blood; Promoting blood circulation to remove blood stasis.Herba Schizonepetae: taste is flat, and warm in nature, nontoxic, faint scent is dense.Herba Schizonepetae is diaphoresis, and antipyretic is one of conventional medical herbs of China.Energy town expectorant, timid wind, removing heat from blood.After Fructus Leonuri is air-dry by the mature fruit of labiate Herba Leonuri, form; Pungent, bitter, be slightly cold.GUIXIN bag, Liver Channel.There is the function of promoting blood flow to regulate menstruation, liver heat removing and eyesight improving.Radix Paeoniae Alba (formal name used at school: Paeonia sterniana Fletcher in Journ.) also claims Paeonia sterniana Fletcher in Journ., is Ranunculaceae Paeonia plant.Bitter in the mouth is flat.Enter liver, spleen channel.Nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing is received antiperspirant.Radix Ophiopogonis: sweet, micro-hardship, is slightly cold.GUIXIN, lung, stomach warp.Colla Corii Asini: the YIN nourishing of enriching blood, moisturize hemostasis.For blood deficiency and yellow complexion, dizzy cardiopalmus, dysphoria and insomnia, xeropulmonary cough.Poria: sweet in the mouth, light, property are flat, be used as medicine there is promoting diuresis to eliminate damp pathogen, the function of strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming.Radix Arnebiae (Radix Lithospermi) (formal name used at school: Lithospermum erythrorhizon) is the plant of Boraginaceae Lithospermum.Nature and flavor: cold in nature, sweet in the mouth, salty returning through GUIXIN, Liver Channel.Function cures mainly removing heat from blood, invigorates blood circulation, and removing toxic substances rash.For heat in blood poison contain, macule purple is black, measles without adequate eruption.Radix Adenophorae (Radix Glehniae): nature and flavor are sweet is cool.Hardship, is slightly cold, nontoxic.Clearing away heat and nourishing YIN, nourishing the lung to arrest cough.Herba Peristrophes Acanthaceae Premna microphylla Turez belongs to herbaceos perennial, is distributed in Japan and southern area of China; Acrid in the mouth; Micro-hardship; Sweet; Cool in nature.Expelling wind and clearing away heat; Cool liver arresting convulsion; Dissipating blood stasis removing toxic substances.Rhizoma Anemones Altaicae is the rhizome of ranunculaceae plant anemone altaica.Latin plant animal mineral name: Anemone altaica Fisch.ex C.A.Mey; Nature and flavor: pungent; Temperature is returned through the heart; Liver; Spleen channel.Function cures mainly: waking up the patient from unconsciousness by dissipating phlegm; Calm the nerves; A surname is wet to be amusing; Removing toxic substances.Folium Indigoferae teysmannii is the leaf of dicotyledon medicine leguminous plant Ti Shi Folium et Caulis Indigoferae Tinctoriae.Cool in nature, sweet-bitter flavor; Removing toxic substances, controls mastitis.Herba Veronicae Ciliatae Scrophulariaceae brooklime Herba Veronicae ciliatae.Nature and flavor: bitter, puckery, cold.Function cures mainly: heat-clearing and toxic substances removing, expelling wind and removing dampness.For rheumatalgia, urticaria.Folium Hibisci Rosae-Sinensis is the leaf of Malvaceae plant Hibiscus rosasinensis: nature and flavor: sweet, flat, nontoxic.Control carbuncle, skin infection, epistaxis." Fujian traditional herbal medicine ": " relieving heat toxin, subduing inflammation." Fructus Kochiae: cold in nature, acrid in the mouth, hardship.Function: clearing away heat-damp and promoting diuresis, dispelling wind for relieving itching." not Lu ": steam in peeling skin, loose malignant boil, hernia abdominal mass, reinforcing YIN-essence, makes people moist.White Radix Solani Melongenae is dry root and the stem foot of plant of Solanaceae eggplant Solanum melongena Linnaeus.Sweet, pungent, cold.Return stomach, large intestine channel.Function cures mainly: loose blood, detumescence, damp eliminating.For rheumatic arthralgia, chilblain.Radix Angelicae Sinensis: nature and flavor: sweet in the mouth; Pungent; Bitter; Warm in nature.Return liver; The heart; Spleen channel.Effect: enrich blood; Invigorate blood circulation; Menstruction regulating and pain relieving; Moisturize laxation.Radix Salviae Miltiorrhizae: bitter in the mouth, be slightly cold, nontoxic.Enter the heart, Liver Channel.Effect: promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind.Folium Lycii is that dicotyledon medicine Solanaceae is planted the young stem and leaf of Fructus Lycii or lycium barbarum.Bitter in the mouth is flat, puckery, nontoxic.Enter the heart, lung, spleen, kidney four warps.Function: the liver and the kidney tonifying, promoting the production of body fluid to quench thirst, expelling wind and removing dampness, blood circulation promoting and blood stasis dispelling.Radix Tripterygii Wilfordii: bitter in the mouth, pungent, cool in nature, poison greatly.Return liver, kidney channel.Effect expelling wind and removing dampness, removing obstruction in the collateral to relieve pain, reducing swelling and alleviating pain, removing toxic substances parasite killing.All medicines merge, and pharmaceutical composition of the present invention has clearing away heat-damp and promoting diuresis, effect of dispelling wind for relieving itching.Remarkable to treatment psoriasis effect, have no side effect.
Experimental example two, model case
Case 1: Wang, man, 56 years old, workman.History of psoriasis more than 20 years, increases the weight of 5 years.This patient chanced on right ancon and occurs desquamation, pruritus before more than 20 year, do not give attention.Subsequently, in succession there is pathological changes in bilateral ancon, lower back, scalp portion.Patient was once coated with the treatment of hormones liniment outside voluntarily in family, had certain curative effect, but outbreak repeatedly, symptom obviously increases the weight of in recent years.Disease is seen the thick long-pending silver bits of scalp, and bilateral ancon, lower back skin be general to become damp redly, accompanies a large amount of white plates desquamations, and cortex is firmly thick, and withered crowfoot cracks are with hemorrhage, and drier, convulsion is itched hard to bear, is afraid of cold, and diet is few, and sleep poor night, once still can, dim red, the tongue root Huang of tongue, arteries and veins CHI-pulse being weak.Previously hypertension history 3 years, cerebral infarction medical history 1 year, diabetes medical history 1 year, has denied Inheritance medical history.Diagnosis: psoriasis vulgaris.Take after 1 course for the treatment of (9 days per courses for the treatment of) of capsule of the present invention (according to embodiment 1 method preparation), the thick long-pending squama attenuation of hair, whole body engenders the normal skin of lamellar, and diffusivity flushing infiltrates and long-pending reducing, and desquamation minimizing degree is thin.After 2 courses for the treatment of of rear continual cure, skin depth without a head amasss squama, and whole skin recovers normally substantially, and flushing speckle obviously reduces, and color is light, closely normal, without desquamation, and without itching over the body, the peace of sleeping night.After half a year, follow up a case by regular visits to satisfactory effect, not recurrence.
Case 2: high certain, man, 60 years old.Lower limb distribute erythema more than ten years, cover squama, lesions position pachyderma.
Diagnosis: psoriasis (homeliness type), take after 2 courses for the treatment of (9 days per courses for the treatment of) of tablet of the present invention (according to embodiment 2 methods preparations), lower limb erythema reduces repairs, and continues to strengthen 2 courses for the treatment of, and it is normal that skin recovers substantially, speckle obviously reduces, color is light, closely normal, without desquamation, without itching over the body, the peace of sleeping night.After half a year, follow up a case by regular visits to satisfactory effect, not recurrence.
Case 3: Wang, female, 48 years old.History of psoriasis more than 10 years, increases the weight of 4 years.This patient chanced on left ancon and occurs desquamation, pruritus before more than 10 year.Subsequently, in succession there is pathological changes in bilateral ancon, scalp portion.Patient was once coated with the treatment of hormones liniment outside voluntarily in family, had certain curative effect, but outbreak repeatedly, symptom obviously increases the weight of in recent years.Disease is seen the thick long-pending silver bits of scalp, and bilateral ancon, lower back skin be general to become damp redly, accompanies a large amount of white plates desquamations, and cortex is firmly thick, and withered crowfoot cracks are with hemorrhage, and convulsion is itched hard to bear, is afraid of cold, and diet is few, and sleep poor night, dim red, the arteries and veins CHI-pulse being weak of tongue.Diagnosis: psoriasis vulgaris.Take after 2 courses for the treatment of (9 days per courses for the treatment of) of granule of the present invention (according to embodiment 3 methods preparations), the thick long-pending squama attenuation of hair, whole body engenders the normal skin of lamellar, and diffusivity flushing infiltrates and long-pending reducing, and desquamation minimizing degree is thin.After 1 course for the treatment of of rear continual cure, recovery from illness.
Following embodiment all can realize the effect of above-mentioned experimental example.
Embodiment 1 capsule
Radix Angelicae Dahuricae 20kg Cortex Dictamni 20kg Radix Rehmanniae 12kg
Radix Isatidis 20kg Cortex Moutan 20kg Herba Schizonepetae 10kg
Fructus Leonuri 15kg Radix Paeoniae Alba 25kg 20kg Radix Ophiopogonis
Colla Corii Asini 20kg Poria 15kg Radix Arnebiae (Radix Lithospermi) 20kg
Radix Adenophorae (Radix Glehniae) 15kg Herba Peristrophes 8kg
Rhizoma Anemones Altaicae 8kg Folium Indigoferae teysmannii 8kg
Herba Veronicae Ciliatae 8kg Folium Hibisci Rosae-Sinensis 12kg Fructus Kochiae 12kg
White Radix Solani Melongenae 15kg Radix Angelicae Sinensis 15kg Radix Salviae Miltiorrhizae 15kg
Folium Lycii 20kg Radix Tripterygii Wilfordii 20kg.
Add conventional adjuvant to make capsule according to common process said medicine, each serving 4, every day 3 times, one after each meal.
Embodiment 2 tablets
Radix Angelicae Dahuricae 12kg Cortex Dictamni 28kg Radix Rehmanniae 8kg
Radix Isatidis 28kg Cortex Moutan 12kg Herba Schizonepetae 13kg
Fructus Leonuri 9kg Radix Paeoniae Alba 36kg 12kg Radix Ophiopogonis
Colla Corii Asini 28kg Poria 9kg Radix Arnebiae (Radix Lithospermi) 28kg
Radix Adenophorae (Radix Glehniae) 9kg Herba Peristrophes 10kg
Rhizoma Anemones Altaicae 6kg Folium Indigoferae teysmannii 10kg
Herba Veronicae Ciliatae 6kg Folium Hibisci Rosae-Sinensis 16kg Fructus Kochiae 8kg
White Radix Solani Melongenae 21kg Radix Angelicae Sinensis 9kg Radix Salviae Miltiorrhizae 21kg
Folium Lycii 12kg Radix Tripterygii Wilfordii 28kg.
Add conventional adjuvant to make tablet according to common process said medicine.
Embodiment 3 granules
Radix Angelicae Dahuricae 28kg Cortex Dictamni 12kg Radix Rehmanniae 16kg
Radix Isatidis 12kg Cortex Moutan 28kg Herba Schizonepetae 7kg
Fructus Leonuri 21kg Radix Paeoniae Alba 14kg 28kg Radix Ophiopogonis
Colla Corii Asini 12kg Poria 21kg Radix Arnebiae (Radix Lithospermi) 12kg
Radix Adenophorae (Radix Glehniae) 21kg Herba Peristrophes 6kg
Rhizoma Anemones Altaicae 10kg Folium Indigoferae teysmannii 6kg
Herba Veronicae Ciliatae 10kg Folium Hibisci Rosae-Sinensis 8kg Fructus Kochiae 16kg
White Radix Solani Melongenae 9kg Radix Angelicae Sinensis 21kg Radix Salviae Miltiorrhizae 9kg
Folium Lycii 28kg Radix Tripterygii Wilfordii 12kg.
Said medicine is added to the agent of conventional adjuvant granulation according to common process.
Embodiment 4 pills
Radix Angelicae Dahuricae 20kg Cortex Dictamni 20kg Radix Rehmanniae 12kg
Radix Isatidis 20kg Cortex Moutan 20kg Herba Schizonepetae 10kg
Fructus Leonuri 15kg Radix Paeoniae Alba 25kg 20kg Radix Ophiopogonis
Colla Corii Asini 20kg Poria 15kg Radix Arnebiae (Radix Lithospermi) 20kg
Radix Adenophorae (Radix Glehniae) 15kg Herba Peristrophes 8kg
Rhizoma Anemones Altaicae 8kg Folium Indigoferae teysmannii 8kg
Herba Veronicae Ciliatae 8kg Folium Hibisci Rosae-Sinensis 12kg Fructus Kochiae 12kg
White Radix Solani Melongenae 15kg Radix Angelicae Sinensis 15kg Radix Salviae Miltiorrhizae 15kg
Folium Lycii 20kg Radix Tripterygii Wilfordii 20kg.
Add conventional adjuvant to make pill according to common process said medicine.
Embodiment 5 oral liquids
Radix Angelicae Dahuricae 28kg Cortex Dictamni 12kg Radix Rehmanniae 16kg
Radix Isatidis 12kg Cortex Moutan 28kg Herba Schizonepetae 7kg
Fructus Leonuri 21kg Radix Paeoniae Alba 14kg 28kg Radix Ophiopogonis
Colla Corii Asini 12kg Poria 21kg Radix Arnebiae (Radix Lithospermi) 12kg
Radix Adenophorae (Radix Glehniae) 21kg Herba Peristrophes 6kg
Rhizoma Anemones Altaicae 10kg Folium Indigoferae teysmannii 6kg
Herba Veronicae Ciliatae 10kg Folium Hibisci Rosae-Sinensis 8kg Fructus Kochiae 16kg
White Radix Solani Melongenae 9kg Radix Angelicae Sinensis 21kg Radix Salviae Miltiorrhizae 9kg
Folium Lycii 28kg Radix Tripterygii Wilfordii 12kg.
Add conventional adjuvant to make oral liquid according to common process said medicine.

Claims (3)

1. the psoriatic pharmaceutical composition for the treatment of, is characterized in that, the crude drug of said composition consists of:
2. pharmaceutical composition as claimed in claim 1, is characterized in that this pharmaceutical composition adds conventional adjuvant to make the pill of clinical acceptance, capsule, tablet, granule, powder, decoction or oral liquid according to common process.
3. the application of pharmaceutical composition as claimed in claim 1 in the psoriatic medicine of preparation treatment.
CN201310218793.XA 2013-06-05 2013-06-05 Medicine composition for treating psoriasis Expired - Fee Related CN103263577B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310218793.XA CN103263577B (en) 2013-06-05 2013-06-05 Medicine composition for treating psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310218793.XA CN103263577B (en) 2013-06-05 2013-06-05 Medicine composition for treating psoriasis

Publications (2)

Publication Number Publication Date
CN103263577A CN103263577A (en) 2013-08-28
CN103263577B true CN103263577B (en) 2014-12-10

Family

ID=49007271

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310218793.XA Expired - Fee Related CN103263577B (en) 2013-06-05 2013-06-05 Medicine composition for treating psoriasis

Country Status (1)

Country Link
CN (1) CN103263577B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105641400A (en) * 2016-01-29 2016-06-08 刘志朋 Traditional Chinese medicine for treating head and face psoriasis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102416099A (en) * 2011-11-29 2012-04-18 王莲芬 Traditional Chinese medicine for treating psoriasis

Also Published As

Publication number Publication date
CN103263577A (en) 2013-08-28

Similar Documents

Publication Publication Date Title
CN103520572A (en) Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition
CN103182019B (en) Traditional Chinese medicine composition for treating ROU (recurrent oral ulcer)
CN103977368A (en) Traditional Chinese medicinal composition for treating arthralgia caused by rheumatic chills and fever and preparation method thereof
CN108186863A (en) A kind of Chinese medicine for treating psoriasis
CN102423433A (en) Traditional Chinese drug mixture for treating psoriasis
CN103263577B (en) Medicine composition for treating psoriasis
CN104189784A (en) Traditional Chinese medicine preparation for aphtha and preparation method of traditional Chinese medicine preparation
CN103301337A (en) Traditional Chinese medicine for treating bovine puerperal fever
CN103007105A (en) Drug composition for curing piles
CN106267098A (en) A kind of can effective Chinese medicine composition treating gout and preparation method thereof
CN103751582B (en) Pharmaceutical composition for the treatment of infantile night sweat and preparation method thereof
CN103239692B (en) Chinese medicine liniment for treating skin itch and preparation method of Chinese medicine liniment
CN112472776A (en) Traditional Chinese medicine pill for treating gout and preparation method thereof
CN102872252B (en) Medicinal composition for treating rheumatic pain
CN105343313A (en) Traditional Chinese medicinal composition for treating senile skin pruritus and preparation method of traditional Chinese medicinal composition
CN105617322A (en) Traditional Chinese medicine composition for treating psoriasis and preparation method thereof
CN105343578A (en) Medicine composition for treating haemorrhoids
CN104623532A (en) Traditional Chinese medicine composition for treating glioma and preparation method thereof
CN104547941A (en) Traditional Chinese medicine composition for preventing and treating cerebral thrombosis
CN104740405B (en) A kind of Chinese medicine preparation and preparation method for treating anaphylactoid purpura renal damage
CN103432466A (en) Female pelvic inflammatory disease treatment traditional Chinese medicine composition and preparation method thereof
CN102552824B (en) Traditional Chinese medicine prepared prescription for treating psoriasis
CN102357210B (en) Traditional Chinese medicine composition for curing facial acne
CN106344838A (en) Chinese medicinal composition for treating oral ulcer
CN105106674A (en) Traditional Chinese medicine composition for treating senile skin pruritus and preparation method of composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20141210

Termination date: 20150605

EXPY Termination of patent right or utility model